Whole slide imaging (WSI) is the most recent imaging modality being employed by pathology labs worldwide. It is an advanced imaging technique used to produce digital slides. Whole slide imaging is a disruptive technology where glass slides are scanned to produce digital images. Whole slide imaging tools or devices scan conventional glass slides in order to produce digital slides. Digital pathology with WSI has many potential clinical and non-clinical applications. As a result, whole slide imaging is rapidly gaining traction among pathologists for diagnostic, educational, and research purposes.

Market Dynamics:

Increasing adoption of digital pathology, growing applications of digital pathology, increasing incidence of cancer, technological advancements in whole slide imaging, increasing in drug discovery, and growing popularity of virtual slides are major factors expected to propel growth of the global whole slide imaging market over the forecast period.

For instance, in September 2022, Pathomation announced a new release of its cloud-based ‘My Pathomation’ platform for digital pathology as a low-threshold communication and whole slide image sharing platform. It boasts a community of 750 users.

Moreover, in March 2022, Leica Microsystems launched Mica, the world’s first Microhub. A Microhub is a new type of wholly integrated imaging solution that leverages machine learning software, automation tools and unique fluorescence unmixing techniques to automate imaging workflow for researchers, regardless of their microscopy experience levels.

Key features of the study:

• This report provides in-depth analysis of the global whole slide imaging market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global whole slide imaging market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include 3Dhistech, Visiopharm, Philips Healthcare, Olympus Corporation, Nikon Corporation, Leica Biosystems GmbH, Inspirata, Hamamatsu Photonics KK, Definiens, Mikroscan Technologies Inc., Indica Labs, and Ventana Medical Systems Inc., among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global whole slide imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global whole slide imaging market.

Detailed Segmentation:

• Global Whole Slide Imaging Market, By Technology:
• • Scanners
  • IT Infrastructure
  • Viewer
  • Image Management System
• Global Whole Slide Imaging Market, By Application:
• • Telepathology
  • Cytopathology
  • Immunohistochemistry
  • Hematopathologists
• Global Whole Slide Imaging Market, By End User:
• • Education
  • Research
  • Clinical
• Global Whole Slide Imaging Market, By Geography:
• • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
• • 3Dhistech
  • Visiopharm
  • Philips Healthcare
  • Olympus Corporation
  • Nikon Corporation
  • Leica Biosystems GmbH
  • Inspirata
  • Indica Labs
  • Hamamatsu Photonics KK
  • Definiens AG
  • Mikroscan Technologies Inc.
  • Ventana Medical Systems Inc.